Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AIDSVAX B/E in intravenous drug users
NCT00006327Phase 3Completed
- Sponsor
- diadexus
- Start
- Mar 1999
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of AIDSVAX B/E in human immunodeficiency virus infection (HIV), sponsored by diadexus. Started Mar 1999; status: completed.
02
Drugs
AIDSVAX B/E
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00006327.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006327.